Drawing for PRIVECTO

USPTO serial 87219022

PRIVECTO

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
SALCIDO, JOHN CHARLES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PRIVECTO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

MAURY M. TEPPER, III TEPPER & EYSTER, PLLC3724 BENSON DRIVERALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of respiratory diseases and asthmaABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 16, 2020MAB5ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION—
Jan 16, 2020ABN5ABANDONMENT - AFTER PUBLICATION—
Jan 15, 2020EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Aug 22, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 21, 2019EX5GSOU EXTENSION 5 GRANTED—
Aug 21, 2019AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 18, 2019EXT5SOU EXTENSION 5 FILED—
Aug 18, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 19, 2019EX4GSOU EXTENSION 4 GRANTED—
Feb 19, 2019EXT4SOU EXTENSION 4 FILED—
Feb 19, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 21, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 19, 2018EX3GSOU EXTENSION 3 GRANTED—
Aug 19, 2018EXT3SOU EXTENSION 3 FILED—
Aug 19, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 23, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 21, 2018EX2GSOU EXTENSION 2 GRANTED—
Feb 21, 2018EXT2SOU EXTENSION 2 FILED—
Feb 21, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 19, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 17, 2017EX1GSOU EXTENSION 1 GRANTED—
Aug 17, 2017EXT1SOU EXTENSION 1 FILED—
Aug 17, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 21, 2017NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 27, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 27, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 7, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 17, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 16, 2016DOCKASSIGNED TO EXAMINER—
Nov 2, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance